2.3 Perinatal Mental Health Assessment & Emergency Psychiatric Care

Perinatal Mental Health Assessment & Emergency Psychiatric Care

Perinatal mental health represents one of the most critical domains of contemporary UK midwifery. According to national MBRRACE-UK surveillance reports, maternal suicide remains a leading cause of direct and late maternal death between six weeks and one year following birth. The NMC Future Midwife standards mandate that registered midwives possess the clinical competence to assess mental well-being, identify early warning signs of psychiatric distress, implement universal screening tools, and initiate emergency escalation when psychiatric emergencies arise.

---

The Spectrum of Perinatal Mental Health Disorders

The perinatal period spans from the point of conception through the end of the first postpartum year. Hormonal fluctuations, sleep deprivation, neurochemical adjustments, and profound psychosocial transitions interact to render this a period of heightened vulnerability.

                               Perinatal Mental Health Clinical Spectrum
                                                  │
          ┌───────────────────────────────────────┼───────────────────────────────────────┐
          ▼                                       ▼                                       ▼
┌────────────────────────────┐      ┌────────────────────────────┐      ┌────────────────────────────┐
│         Baby Blues         │      │  Perinatal Mood & Anxiety  │      │    Postpartum Psychosis    │
├────────────────────────────┤      ├────────────────────────────┤      ├────────────────────────────┤
│ • Up to 80% of new mothers │      │ • PND, Anxiety, Tokophobia │      │ • 1 to 2 per 1,000 births  │
│ • Onset days 3 to 5        │      │ • Birth-related PTSD & OCD │      │ • Onset days 2 to 14       │
│ • Emotional lability, teary│      │ • Persistent low mood, fear│      │ • Delusions, mania, confusion│
│ • Resolves by day 10 to 14 │      │ • Requires therapy / SSRIs │      │ • Acute Medical Emergency  │
│ • Supportive care only     │      │ • Community PMH referral   │      │ • Emergency MBU Admission  │
└────────────────────────────┘      └────────────────────────────┘      └────────────────────────────┘

1. The Baby Blues (Postpartum Blues)

The baby blues is a transient, physiological state affecting up to 80% of postpartum women. It typically begins on days 3 to 5 following birth, coinciding with rapid postpartum drops in circulating estrogen and progesterone alongside intense surges of prolactin. Clinical manifestations include tearfulness, emotional lability, mild irritability, fatigue, and heightened sensitivity. The baby blues is self-limiting, peaking around day 5 and resolving completely by day 10 to 14 without pharmacological intervention. Midwifery care involves empathetic validation, rest promotion, practical infant support, and reassurance that these feelings are a common physiological transition.

2. Antenatal & Postnatal Depression (PND)

Affecting approximately 10% to 15% of women, perinatal depression can manifest during pregnancy or develop insidiously across the postnatal year. Symptoms include pervasive low mood, anhedonia (inability to experience joy), profound fatigue unrelated to infant care, unrefreshing sleep (inability to sleep even when the baby sleeps peacefully), excessive feelings of guilt, worthlessness, and perceived maternal inadequacy. Women may struggle with maternal-infant bonding, feeling emotionally detached from their baby.

3. Perinatal Anxiety, Tokophobia & Birth Trauma / PTSD

• Generalised Anxiety & Panic: Characterized by constant, uncontrollable worry, somatic tension, tachycardia, and catastrophic anticipation regarding the baby's health or survival.
• Tokophobia: A severe, pathological dread and avoidance of pregnancy and childbirth. Primary tokophobia manifests in nulliparous women, often originating in early life trauma; secondary tokophobia is triggered by traumatic obstetric events in previous births. Midwives must identify tokophobia early, facilitating psychological support and informed discussions regarding birth options, including planned caesarean birth.
• Post-Traumatic Stress Disorder (PTSD) & Birth Trauma: Affects approximately 3% to 4% of postpartum women following an actual or perceived threat of severe injury or death during labour, birth, or the immediate neonatal period. Features intrusive flashbacks, nightmares, psychological hyperarousal, and active avoidance of healthcare facilities or birth reminders.

4. Perinatal Obsessive-Compulsive Disorder (OCD)

Perinatal OCD is a frequently misunderstood condition characterised by recurrent, intrusive, and distressing ego-dystonic thoughts, images, or impulses. These thoughts frequently centre on harm coming to the baby—such as accidental dropping, drowning in the bath, suffocation, or horrific thoughts of deliberate violence (e.g., stabbing or poisoning).

Universal Identification & Screening Protocols

NICE clinical guideline CG192 (Antenatal and postnatal mental health) advises that, at a woman's first contact with services or booking visit and again in the early postnatal period, the midwife considers asking the Whooley depression questions and the GAD-2 anxiety questions. NICE antenatal care (NG201) and postnatal care (NG194) guidance adds that midwives should ask about mental health and emotional wellbeing at every antenatal and postnatal contact, so identification is continuous rather than a one-off screen.

The Whooley Questions

The Whooley questions represent a validated, two-item screening instrument designed to detect depressive disorders in primary and maternity care:

1. "During the past month, have you often been bothered by feeling down, depressed, or hopeless?"
2. "During the past month, have you often been bothered by having little interest or pleasure in doing things?"

If the woman answers "yes" to either question, the midwife asks the third validation/help question:

• "Is this something you feel you need or want help with?"

Anxiety Identification (GAD-2 & GAD-7)

To identify generalised anxiety disorder, midwives employ the GAD-2 screening questions:

1. "During the past month, have you often been bothered by feeling nervous, anxious, or on edge?"
2. "During the past month, have you often been bothered by not being able to stop or control worrying?"

A positive response to the GAD-2 prompts completion of the full GAD-7 questionnaire to grade anxiety severity (mild: 5–9, moderate: 10–14, severe: 15–21).

The Edinburgh Postnatal Depression Scale (EPDS)

The EPDS is a 10-item self-report questionnaire widely utilized in community postnatal midwifery and health visiting. A score of 10 to 12 indicates possible mild-to-moderate depression, while a score of 13 or greater indicates probable major depressive illness. Crucially, Item 10 specifically evaluates suicidal ideation ("The thought of harming myself has occurred to me"). Any positive score on Item 10 demands immediate clinical evaluation of suicidal intent and emergency psychiatric assessment, irrespective of the total score.

Family & Psychiatric History Inquiry

Midwives must directly inquire whether the woman has a personal or family (first-degree relative) history of severe mental illness, specifically bipolar affective disorder or postpartum psychosis. Women with pre-existing bipolar disorder face a 25% to 50% risk of developing an acute recurrence or postpartum psychosis following birth. These women require pre-conception or early antenatal referral to specialist perinatal mental health services to formulate a detailed multidisciplinary postpartum care plan.

Psychiatric Red Flags & Emergency Escalation

While most perinatal mental health presentations can be managed through primary care talking therapies (NHS Talking Therapies) or community perinatal mental health teams (PMHT), midwives must remain hyper-vigilant for psychiatric red flags that denote acute, life-threatening decompensation.

Red Flag Clinical Symptoms

Immediate same-day emergency psychiatric escalation (crisis resolution team, duty liaison psychiatrist, or on-call perinatal consultant) is required if a woman presents with:

• Rapidly Fluctuating Mood: Extreme shifts between euphoria, tearfulness, profound agitation, and severe panic within hours.
• Manic Symptoms: Markedly elevated energy, pressured speech, racing thoughts, grandiose ideas, and lack of need for sleep without feeling fatigued.
• Delusional Beliefs or Hallucinations: Fixed, false beliefs, particularly involving the baby (e.g., beliefs that the infant is possessed, evil, dead, deformed despite normal examination, or not hers) or auditory/command hallucinations.
• Cognitive Disorientation & Confusion: Clouding of consciousness, perplexity, acute memory lapses, or delirium-like state.
• Active Suicidal Plans or Intent: Explicit expressions of wanting to end her life, acquiring lethal means, or having violent thoughts of self-harm.
• Thoughts of Violent Harm to the Baby: Thoughts of harming the baby accompanied by intent, conviction, or lack of emotional distress.

Postpartum Psychosis: Emergency Management & MBUs

Postpartum psychosis (puerperal psychosis) is a severe, life-threatening psychiatric emergency affecting approximately 1 to 2 per 1,000 women following childbirth. Unlike postnatal depression, which develops gradually over weeks or months, postpartum psychosis has an explosive, dramatic onset, usually presenting within the first two weeks postpartum (frequently between days 2 and 7).

Clinical Presentation & Risk Factors

The earliest warning sign is often intractable insomnia—the woman remains completely wide awake for days on end despite severe exhaustion. This progresses rapidly to manic hyperactivity, pressured speech, tangential thoughts, profound agitation, bizarre behavior, persecutory delusions, and auditory hallucinations. Delusions frequently focus on the newborn: the mother may believe the infant is an evil entity, possessed by demons, deceased, or having messianic properties.

Risk factors include:

• Bipolar Affective Disorder: History of bipolar disorder confers a 25% to 50% recurrence risk.
• Previous Postpartum Psychosis: Carries a 50% risk of recurrence in subsequent pregnancies.
• Family History: First-degree relative with postpartum psychosis or bipolar disorder.

Emergency Management

Because postpartum psychosis carries a catastrophic risk of acute maternal suicide or infanticide (filicide), it must be treated with the same urgency as severe postpartum haemorrhage or eclampsia:

1. Continuous Supervision: The mother must never be left alone with the infant or left unattended in a room while awaiting assessment.
2. Emergency Referral: Contact the on-call perinatal psychiatric crisis team or emergency mental health liaison immediately for urgent same-day evaluation.
3. Medical Exclusion: Ensure underlying medical causes of delirium (such as postpartum sepsis, cerebral venous sinus thrombosis, or thyroid storm) are ruled out with physical observations and urgent blood tests.

Mother and Baby Units (MBUs)

When inpatient psychiatric admission is required, UK national guidelines dictate that the woman must be admitted to a specialized Mother and Baby Unit (MBU) alongside her baby.

---

Psychotropic Medications in Pregnancy & Lactation

Managing psychiatric medications in pregnancy and breastfeeding requires balancing the potential risks of fetal medication exposure against the well-documented, catastrophic risks of untreated maternal mental illness. Abrupt cessation of psychotropic medications upon discovering pregnancy is a dangerous, common error that precipitates rapid clinical relapse.

Selective Serotonin Reuptake Inhibitors (SSRIs)

SSRIs are the primary pharmacological agents prescribed for perinatal depression, generalized anxiety, and OCD.

• Sertraline: Considered the first-line SSRI in lactation. Sertraline has an exceptionally low relative infant dose (RID roughly 0.5–2%), meaning negligible amounts transfer into breast milk, and infant serum levels are usually undetectable.
• Citalopram & Fluoxetine: Widely used; fluoxetine has an active metabolite with a long elimination half-life, resulting in higher infant breast milk concentrations.
• Paroxetine: Avoided during the first trimester due to epidemiological evidence demonstrating a small increased risk of congenital cardiovascular malformations (ventricular and atrial septal defects).
• Neonatal Effects:
  • Poor Neonatal Adaptation Syndrome (PNAS): Occurs in up to 30% of neonates exposed to late-trimester SSRIs. Manifests as mild, transient jitteriness, irritability, temperature instability, and poor feeding within the first 48 hours. PNAS is self-limiting and resolves within days with supportive care.
  • Persistent Pulmonary Hypertension of the Newborn (PPHN): A rare cardiovascular condition with a small statistical association with late-pregnancy SSRI exposure (absolute risk rises from ~1.5 per 1,000 to ~3 per 1,000 live births).

Mood Stabilisers & Teratogenicity

                    ┌────────────────────────────────────────────────────────┐
                    │          Teratogenicity of Mood Stabilisers            │
                    └────────────────────────────────────────────────────────┘
                                                │
          ┌─────────────────────────────────────┴─────────────────────────────────────┐
          ▼                                                                           ▼
┌───────────────────────────────────────────┐               ┌───────────────────────────────────────────┐
│         Sodium Valproate (Epilim)         │               │                  Lithium                  │
├───────────────────────────────────────────┤               ├───────────────────────────────────────────┤
│ • Must not be used if able to become      │               │ • Historical link to Ebstein's anomaly   │
│   pregnant unless Prevent (PPP) is met    │               │   (absolute risk ~1-2 per 1,000)          │
│ • 10% risk of major congenital defects    │               │ • Requires intensive therapeutic drug     │
│   (neural tube defects, cleft palate)     │               │   monitoring (TDM) due to altered GFR     │
│ • 30% to 40% risk of neurodevelopmental   │               │ • Withhold during active labour to avoid  │
│   disorders, autism, and cognitive delay  │               │   maternal-fetal toxicity & dehydration   │
└───────────────────────────────────────────┘               └───────────────────────────────────────────┘

Lithium Management

Lithium remains an effective mood stabilizer for bipolar disorder, but requires meticulous perinatal management:

• Teratogenic Profile: Historically associated with Ebstein's anomaly (a congenital cardiac tricuspid valve defect), though modern registry data indicates the absolute risk is relatively small (~1 to 2 per 1,000 births compared to 1 per 20,000 in the general population).
• Physiological Monitoring: Expanding maternal plasma volume and increased glomerular filtration rate (GFR) during pregnancy accelerate lithium clearance, requiring close serum level monitoring (NICE CG192: every 4 weeks, then weekly from 36 weeks; stop during labour and check the level 12 hours after the last dose).
• Labour Management: Maternal dehydration during labour can precipitate acute lithium toxicity. Lithium is routinely withheld at the onset of established labour or 24 hours prior to elective caesarean birth, with careful intravenous fluid balance maintained.